Latest News and Press Releases

SAN DIEGO, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a biotechnology company pioneering the development of targeted genetic...

MALVERN, Pa., Feb. 09, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced the...

All patients dosed with SPVN06 in Phase I/II trial continue to demonstrate a favorable safety profileInitial data readout for this novel gene-agnostic therapy expected in 2027 Paris, February 9,...

~ Supraphysiological expression of α-Gal A activity maintained for over a year in longest treated patient as of data cutoff date ~ ~ Stable Lyso-Gb3 levels maintained post-dosing, regardless of...

Pluristyx and Solesis launch ready-to-use kit combining high-quality pluripotent cells and mRNA technology with proprietary transfection technology

Spur Therapeutics Presents New Phase 1/2 Data on Its Gene Therapy Candidate in Gaucher Disease at 22nd Annual WORLDSymposium

SANGAMO THERAPEUTICS PRESENTS DETAILED DATA FROM REGISTRATIONAL STAAR STUDY IN FABRY DISEASE AT WORLDSYMPOSIUM 2026

Dublin, Jan. 29, 2026 (GLOBE NEWSWIRE) -- The "Nucleic Acid Therapeutics Contract Manufacturing Market Size, Share & Trends Analysis Report by Type (Gene Therapy, RNA-based Therapies), Service,...

Dublin, Jan. 29, 2026 (GLOBE NEWSWIRE) -- The "North America, Europe & Asia-Pacific Gene Therapy Cell Culture Media Market Forecast to 2033" report has been added to ResearchAndMarkets.com's...

Siren Biotechnology Announces FDA Clearance of First IND, Advancing Company to Clinical Stage